Current status of islet cell transplantation

Advances in Surgery

Volumn 37, Issue , 2003, Pages 253-282

  Oberholzer, José ^a,b   Shapiro, A M James ^a,c   Lakey, Jonathan R T ^a   Ryan, Edmond A ^a,c   Rajotte, Ray V ^a   Korbutt, Gregory S ^a   Morel, Philippe ^b   Kneteman, Norman M ^a,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Capital Health Edmonton   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; RAPAMYCIN; TSUKUBAENOLIDE;

ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ALLOTRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; CELL LINEAGE; CLINICAL RESEARCH; DISEASE TRANSMISSION; EMBRYONIC STEM CELL; GLUCOSE BLOOD LEVEL; GRAFT INFECTION; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LOW DRUG DOSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PORTAL VEIN THROMBOSIS; REVIEW; XENOGRAFT; XENOTRANSPLANTATION; ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; FORECASTING; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HOSPITALIZATION; MALE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; FORECASTING; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0141921399     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (139)

1. Williams PW: Notes on diabetes treated with grafts of sheep's pancreas. Br Med J 2:1303, 1894.
2. Scharp DW, Lacy PE, Santiago JV, et al: Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation 51:76-85, 1991.
3. Warnock GL, Kneteman NM, Ryan EA, et al: Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:89-95, 1992.
4. Gores PF, Najarian JS, Stephanian E, et al: Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 341:19-21, 1993.
5. Secchi A, Socci C, Maffi P, et al: Islet transplantation in IDDM patients. Diabetologia 40:225-231, 1997.
6. Alejandro R, Lehmann R, Ricordi C, et al: Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 46:1983-1989, 1997.
7. Bretzel RG, Brandhorst D, Brandhorst H, et al: Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management. J Mol Med 77:140-143, 1999.
8. Oberholzer J, Triponez F, Mage R, et al: Human islet transplantation: Lessons from 13 autologous and 13 allogeneic transplantations. Transplantation 69:1115-1123, 2000.
9. Shapiro AM, Lakey JR, Ryan EA, et al: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000.
10. Lacy PE, Kostianovsky M: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35-39, 1967.
11. Ballinger WF, Lacy PE: Transplantation of intact pancreatic islets in rats. Surgery 72:175-186, 1972.
12. Mirkovitch V, Campiche M: Successful intrasplenic autotransplantation of pancreatic tissue in totally pancreatectomised dogs. Transplantation 21:265-269, 1976.
13. Lorenz D, Reding R, Petermann J, et al: Transplantation of isolated islets of Langerhans into the liver of diabetic dogs. Zentralbl Chir 101:1359-1368, 1976.
14. Najarian JS, Sutherland DE, Matas AJ, et al: Human islet transplantation: A preliminary report. Transplant Proc 9:233-236, 1977.
15. Sutherland DE, Matas AJ, Goetz FC, et al: Transplantation of dispersed pancreatic islet tissue in humans: Autografts and allografts. Diabetes 29:31S-44S, 1980.
16. Walsh TJ, Eggleston JC, Cameron JL: Portal hypertension, hepatic infarction, and liver failure complicating pancreatic islet autotransplantation. Surgery 91:485-487, 1982.
17. Froberg MK, Leone JP, Jessurun J, et al: Fatal disseminated intravascular coagulation after autologous islet transplantation. Hum Pathol 28: 1295-1298, 1997.
18. Ryan EA, Lakey JR, Rajotte RV, et al: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50:710-719, 2001.
19. Keymeulen B, Ling Z, Gorus F, et al: Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: Graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 41:452-459, 1998.
20. Brandhorst D, Brandhorst H, Brendel M, et al: Problems of islet isolation from the human and porcine pancreas for islet transplantation into men. Zentralbl Chir 123:814-822, 1998.
21. Benhamou PY, Watt PC, Mullen Y, et al: Human islet isolation in 104 consecutive cases. Factors affecting isolation success. Transplantation 57:1804-1810, 1994.
22. Lakey JR, Warnock GL, Rajotte RV, et al: Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 61: 1047-1053, 1996.
23. Toso C, Oberholzer J, Ris F, et al: Factors affecting human islet of Langerhans isolation yields. Transplant Proc 34:826-827, 2002.
24. Brandhorst D, Brandhorst H, Hering BJ, et al: Islet isolation from the pancreas of large mammals and humans: 10 years of experience. Exp Clin Endocrinol Diabetes 103:3S-14S, 1995.
25. Lakey JR, Kneteman NM, Rajotte RV, et al: Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation 73:1106-1110, 2002.
26. Horaguchi A, Merrell RC: Preparation of viable islet cells from dogs by a new method. Diabetes 30:455-458, 1981.
27. Warnock GL, Rajotte RV: Critical mass of purified islets that induce normoglycemia after implantation into dogs. Diabetes 37:467-470, 1988.
28. Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation: Experimental results and evaluation of clinical trials, in Samols E (ed): The Endocrine Pancreas. New York, Raven Press, 1991, pp 487-517.
29. Lakey JR, Warnock GL, Shapiro AM, et al: Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 8:285-292, 1999.
30. Ricordi C, Lacy PE, Finke EH, et al: Automated method for isolation of human pancreatic islets. Diabetes 37:413-420, 1988.
31. Johnson PR, White SA, London NJ: Collagenase and human islet isolation. Cell Transplant 5:437-452, 1996.
32. Linetsky E, Bottino R, Lehmann R, et al: Improved human islet isolation using a new enzyme blend, Liberase. Diabetes 46:1120-1123, 1997.
33. Olack BJ, Swanson CJ, Howard TK, et al: Improved method for the isolation and purification of human islets of Langerhans using Liberase enzyme blend. Hum Immunol 60:1303-1309, 1999.
34. Jahr H, Pfeiffer G, Hering BJ, et al: Endotoxin-mediated activation of cytokine production in human PBMCs by collagenase and Ficoll. J Mol Med 77:118-120, 1999.
35. Eckhardt T, Jahr H, Federlin K, et al: Endotoxin impairs the engraftment of rat islets transplanted beneath the kidney capsule of C57BL/6-mice. J Mol Med 77:123-125, 1999.
36. Alejandro R, Strasser S, Zucker PF, et al: Isolation of pancreatic islets from dogs. Semiautomated purification on albumin gradients. Transplantation 50:207-210, 1990.
37. Soon-Shiong P, Heintz R, Fujioka T, et al: Utilization of anti-acinar cell monoclonal antibodies in the purification of rat and canine islets. Horm Metab Res Suppl 25:45-50, 1990.
38. Behboo R, Carroll PB, Ukah F, et al: One-hour of hypothermic incubation in Euro-Collins improves islet purification. Transplant Proc 26: 645, 1994.
39. Samejima T, Yamaguchi K, Iwata H, et al: Gelatin density gradient for isolation of islets of Langerhans. Cell Transplant 7:37-45, 1998.
40. Lakey JR, Cavanagh TJ, Zieger MA: A prospective comparison of discontinuous EuroFicoll and EuroDextran gradients for islet purification. Cell Transplant 7:479-487, 1998.
41. London NJ, Swift SM, Clayton HA: Isolation, culture and functional evaluation of islets of Langerhans. Diabetes Metab 24:200-207, 1998.
42. Nandigala P, Chen TH, Yang C, et al: Immunomagnetic isolation of islets from the rat pancreas. Biotechnol Prog 13:844-848, 1997.
43. Lukowiak B, Vandewalle B, Riachy R, et al: Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem 49:519-528, 2001.
44. Benhamou PY, Oberholzer J, Toso C, et al: Human islet transplantation network for the treatment of type I diabetes: First data from the Swiss-French GRAGIL consortium (1999-2000). Groupe de Recherche Rhin Rhjne Alpes Geneve pour la transplantation d'Ilots de Langerhans. Diabetologia 44:859-864, 2001.
45. NIH Implementation of the Recommendations of the Congressionally Directed Diabetes Research Working Group, http://www.niddk.nih.gov /federal/dwg/ DRWGREP2.htm, accessed November 2002.
46. National Center for Research Resources NIDDK and JDF: Human Pancreatic Islet Resources (ICRs): Request for application, http://grants.nih.gov/grants/ guide/rfa-files/RFA-RR-01-002.html, accessed November 2002.
47. NIDDK: National Diabetes Statistics, http://www.niddk.nih.gov/health/ diabetes/pubs/dmstats/dmstats.htm#7 2002, accessed November 2002.
48. Rosendale JD, Chabalewski FL, McBride MA, et al: Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2:761-768, 2002.
49. Brandhorst H, Brandhorst D, Hering BJ, et al: Significant progress in porcine islet mass isolation utilizing Liberase HI for enzymatic low-temperature pancreas digestion. Transplantation 68:355-361, 1999.
50. O'Neil JJ, Stegemann JP, Nicholson DT, et al: The isolation and function of porcine islets from market weight pigs. Cell Transplant 10:235-246, 2001.
51. Korbutt GS, Elliott JF, Ao Z, et al: Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 97:2119-2129, 1996.
52. Trivedi N, Hollister-Lock J, Lopez-Avalos MD, et al: Increase in beta-cell mass in transplanted porcine neonatal pancreatic cell clusters is due to proliferation of beta-cells and differentiation of duct cells. Endocrinology 142:2115-2122, 2001.
53. Korsgren O, Groth CG, Andersson A, et al: Transplantation of porcine fetal pancreas to a diabetic patient. Transplant Proc 24:352-353, 1992.
54. Groth CG, Korsgren O, Tibell A, et al: Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344:1402-1404, 1994.
55. Hering BJ, Ricordi C: Islet transplantation for patients with type 1 diabetes. Graft 2:12-27, 1999.
56. Elliott RB, Escobar L, Garkavenko O, et al: No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant 9:895-901, 2000.
57. Valdes-Gonzalez RA, Elliott RB, Dorantes LM, et al: Porcine islet xenografts can survive and function in type 1 diabetic patients in the presence of both pre-existing and elicited anti-pig antibodies. Transplantation 74:94S, 2002.
58. Bach FH: Xenotransplantation: Problems and prospects. Annu Rev Med 49:301-310, 1998.
59. Bach FH, Fishman JA, Daniels N, et al: Uncertainty in xenotransplantation: Individual benefit versus collective risk. Nat Med 4:141-144, 1998.
60. Bach FH, Fineberg HV: Call for moratorium on xenotransplants. Nature 391:326, 1998.
61. Chapman LE, Folks TM, Salomon DR, et al: Xenotransplantation and xenogeneic infections. N Engl J Med 333:1498-1501, 1995.
62. Chapman LE: Xenogeneic infections and public health. Clin Exp Pharmacol Physiol 26:1005-1008, 1999.
63. Fishman JA: Infection and xenotransplantation. Developing strategies to minimize risk. Ann N Y Acad Sci 862:52-66, 1998.
64. Michaels MG, McMichael JP, Brasky K, et al: Screening donors for xenotransplantation. The potential for xenozoonoses. Transplantation 57: 1462-1465, 1994.
65. Michaels MG, Simmons RL: Xenotransplant-associated zoonoses. Strategies for prevention. Transplantation 57:1-7, 1994.
66. Le Tissier P, Stoye JP, Takeuchi Y, et al: Two sets of human-tropic pig retrovirus. Nature 389:681-682, 1997.
67. Patience C, Takeuchi Y, Weiss RA: Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3:282-286, 1997.
68. Wilson CA, Wong S, VanBrocklin M, et al: Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J Virol 74:49-56, 2000.
69. Downing R, Jay TR, Topham DT, et al: Isolation and function of islets from 6-week-old gnotobiotic pigs. Transplant Proc 27:3331-3332, 1995.
70. Ye Y, Niekrasz M, Kosanke S, et al: The pig as a potential organ donor for man. A study of potentially transferable disease from donor pig to recipient man. Transplantation 57:694-703, 1994.
71. Paradis K, Langford G, Long Z, et al: Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 285:1236-1241, 1999.
72. Sedivy JM, Dutriaux A: Gene targeting and somatic cell genetics: A rebirth or a coming of age? Trends Genet 15:88-90, 1999.
73. Polejaeva IA, Chen SH, Vaught TD, et al: Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 407:86-90, 2000.
74. Blusch JH, Patience C, Martin U: Pig endogenous retroviruses and xenotransplantation. Xenotransplantation 9:242-251, 2002.
75. Hunkeler D, Sun AM, Korbutt GS, et al: Bioartificial organs and acceptable risk. Nat Biotechnol 17:1045, 1999.
76. Salmon P, Oberholzer J, Occhiodoro T, et al: Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol Ther 2:404-414, 2000.
77. Dufayet De La Tour D, Halvorsen T, Demeterco C, et al: Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 15:476-483, 2001.
78. Macfarlane WM, Cragg H, Docherty HM, et al: Impaired expression of transcription factor IUF1 in a pancreatic beta-cell line derived from a patient with persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis). FEBS Lett 413:304-308, 1997.
79. Macfarlane WM, O'Brien RE, Barnes PD, et al: Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes 49:953-960, 2000.
80. 2+. Diabetes 49:418-423, 2000.
81. Kerr-Conte J, Pattou F, Lecomte-Houcke M, et al: Ductal cyst formation in collagen-embedded adult human islet preparations. A means to the reproduction of nesidioblastosis in vitro. Diabetes 45:1108-1114, 1996.
82. Gmyr V, Kerr-Conte J, Belaich S, et al: Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: Further evidence for pluripotent pancreatic stem cells in humans. Diabetes 49: 1671-1680, 2000.
83. Gmyr V, Kerr-Conte J, Vandewalle B, et al: Human pancreatic ductal cells: Large-scale isolation and expansion. Cell Transplant 10:109-121, 2001.
84. Bonner-Weir S, Taneja M, Weir GC, et al: In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97:7999-8004, 2000.
85. Ulrich AB, Schmied BM, Standop J, et al: Pancreatic cell lines: A review. Pancreas 24:111-120, 2002.
86. Zulewski H, Abraham EJ, Gerlach MJ, et al: Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50:521-533, 2001.
87. Soria B, Roche E, Berna G, et al: Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49:157-162, 2000.
88. Lumelsky N, Blondel O, Laeng P, et al: Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389-1394, 2001.
89. Lenoir N: Europe confronts the embryonic stem cell research challenge. Science 287:1425-1427, 2000.
90. Wertz DC: Embryo and stem cell research in the USA: A political history. Trends Mol Med 8:143-146, 2002.
91. Wahoff DC, Papalois BE, Najarian JS, et al: Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 222:562-579, 1995.
92. Robertson GS, Dennison AR, Johnson PR, et al: A review of pancreatic islet autotransplantation. Hepatogastroenterology 45:226-235, 1998.
93. White SA, Davies JE, Pollard C, et al: Pancreas resection and islet autotransplantation for end-stage chronic pancreatitis. Ann Surg 233:423-431, 2001.
94. Pipeleers DG, Pipeleers-Marichal M, Vanbrabandt B, et al: Transplantation of purified islet cells in diabetic rats: II. Immunogenicity of allografted islet beta-cells. Diabetes 40:920-930, 1991.
95. Huypens P, Ling Z, Pipeleers D, et al: Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia 43:1012-1019, 2000.
96. Wang RN, Paraskevas S, Rosenberg L: Characterization of integrin expression in islets isolated from hamster, canine, porcine, and human pancreas. J Histochem Cytochem 47:499-506, 1999.
97. Wang RN, Rosenberg L: Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J Endocrinol 163:181-190, 1999.
98. Bertuzzi F, Berra C, Socci C, et al: Glucagon improves insulin secretion from pig islets in vitro. J Endocrinol 147:87-93, 1995.
99. Lou J, Triponez F, Oberholzer J, et al: Expression of alpha-1 proteinase inhibitor in human islet microvascular endothelial cells. Diabetes 48: 1773-1778, 1999.
100. Cepinskas G, Noseworthy R, Kvietys PR: Transendothelial neutrophil migration. Role of neutrophil-derived proteases and relationship to transendothelial protein movement. Circ Res 1:618-626, 1997.
101. Vajkoczy P, Olofsson AM, Lehr HA, et al: Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am J Pathol 146:1397-1405, 1995.
102. Jindal RM, Fineberg SE, Sherman S, et al: Clinical experience with autologous and allogeneic pancreatic islet transplantation. Transplantation 66:1836-1841, 1998.
103. Kneteman NM, Rajotte RV, Procyshyn AW: Canine pancreatic fragment allotransplantation with cyclosporine A. J Surg Res 39:285-293, 1985.
104. Yakimets WJ, Lakey JR, Yatscoff RW, et al: Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses. Rapamycin efficacy is blood level related. Transplantation 56:1293-1298, 1993.
105. Shapiro AM, Geng Hao E, Lakey JR, et al: Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. Transplantation 74:1522-1528, 2002.
106. Zeng Y, Ricordi C, Lendoire J, et al: The effect of prednisone on pancreatic islet autografts in dogs. Surgery 113:98-102, 1993.
107. Merrell RC, Maeda M, Basadonna G, et al: Suppression, stress, and accommodation of transplanted islets of Langerhans. Diabetes 34:667-670, 1985.
108. Basadonna G, Kakizaki K, Merrell RC: Effect of cyclosporine on established islet autografts. J Surg Res 40:450-454, 1986.
109. Kneteman NM, Lakey JR, Wagner T, et al: The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. Transplantation 61:1206-1210, 1996.
110. Brendel MD, Hering B, Schultz AO, et al: International Islet Transplant Registry. Newsletter 8. Justus-Liebig-University of Giessen, Giessen, Germany, 2001.
111. Meyer C, Hering BJ, Grossmann R, et al: Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation 66:233-240, 1998.
112. Luzi L, Perseghin G, Brendel MD, et al: Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 50:277-282, 2001.
113. Ryan EA, Lakey JR, Paty BW, et al: Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157, 2002.
114. Oberholzer J, Toso C, Triponez F, et al: Human islet allotransplantation with basiliximab in type I diabetic patients with end-stage renal failure. Transplant Proc 34:823-825, 2002.
115. Bertuzzi F, Grohovaz F, Maffi P, et al: Succesful transplantation of human islets in recipients bearing a kidney graft. Diabetologia 45:77-84, 2002.
116. Shapiro AM, Hao E, Lakey JR, et al: Diabetogenic synergism in canine islet autografts from cyclosporine and steroids in combination. Transplant Proc 30:527, 1998.
117. Memsic L, Busuttil RW, Traverso LW: Bleeding esophageal varices and portal vein thrombosis after pancreatic mixed-cell autotransplantation. Surgery 95:238-242, 1984.
118. Brattstrom C, Wilczek H, Tyden G, et al: Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin). Transplantation 65:1272-1274, 1998.
119. Lim F, Sun AM: Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908-910, 1980.
120. Mullen Y, Maruyama M, Smith CV: Current progress and perspectives in immunoisolated islet transplantation. J Hepatobiliary Pancreat Surg 7:347-357, 2000.
121. Sachs DH: Immunologic tolerance to organ transplants. J Gastrointest Surg 3:105-110, 1999.
122. Calne RY: Prope tolerance: A step in the search for tolerance in the clinic. World J Surg 24:793-796, 2000.
123. Wekerle T, Sykes M: Mixed chimerism and transplantation tolerance. Annu Rev Med 52:353-370, 2001.
124. Bluestone JA, Matthews JB, Krensky AM: The immune tolerance network: The "Holy Grail" comes to the clinic. J Am Soc Nephrol 11:2141-2146, 2000.
125. Knechtle SJ: Knowledge about transplantation tolerance gained in primates. Curr Opin Immunol 12:552-556, 2000.
126. Kawai T, Andrews D, Colvin RB, et al: Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 6:114, 2000.
127. Monaco AP, Maki T, Ozato H, et al: Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann Surg 214:339-362, 1991.
128. Petruzzo P, Pibiri L, De Giudici MA, et al: Xenotransplantation of microencapsulated pancreatic islets contained in a vascular prosthesis: Preliminary results. Transpl Int 4:200-204, 1991.
129. Altman JJ, Houlbert D, Callard P, et al: Long-term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of benign human insulinomas. Diabetes 35:625-633, 1986.
130. Lanza RP, Chick WL: Experimental pancreatic islet cell xenotransplantation, in Cooper DKC, Kemp E, Platt JL, et al (eds): Xenotransplantation. Berlin, Springer, 1997, pp 534-544.
131. O'Shea GM, Goosen MF, Sun AM: Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta 804:133-136, 1984.
132. Sun Y, Ma X, Zhou D, et al: Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 98:1417-1422, 1996.
133. De Vos P, Van Straaten JF, Nieuwenhuizen AG, et al: Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 48:1381-1388, 1999.
134. Lanza RP, Ecker DM, Kuhtreiber WM, et al: Transplantation of islets using microencapsulation: Studies in diabetic rodents and dogs. J Mol Med 77:206-210, 1999.
135. Duvivier-Kali VF, Omer A, Parent RJ, et al: Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50:1698-1705, 2001.
136. De Vos P, Vegter D, De Haan BJ, et al: Kinetics of intraperitoneally infused insulin in rats. Functional implications for the bioartificial pancreas. Diabetes 45:1102-1107, 1996.
137. Kessler L, Jesser C, Lombard Y, et al: Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: In vivo and in vitro studies. J Leukoc Biol 60:729-736, 1996.
138. Leblond FA, Simard G, Henley N, et al: Studies on smaller (approximately 315 microM) microcapsules: IV. Feasibility and safety of intrahepatic implantations of small alginate poly-L-lysine microcapsules. Cell Transplant 8:327-337, 1999.
139. Toso C, Oberholzer J, Ceausoglu I, et al: Intraportal injections of 400mm multicomponent microcapsules in a large animal model. Transpl Int 16/9, 2003.